Most Recent Mortality Impact of GLP-1 Drugs By Richard Russell Andrew Gaskell Raman Lalia Craig Armstrong Chris Falkous RGA study finds incretin drugs could reduce mortality up to 8.8%, so insurers should reassess assumptions.
Mortality Impact of GLP-1 Drugs By Richard Russell Andrew Gaskell Raman Lalia Craig Armstrong Chris Falkous RGA study finds incretin drugs could reduce mortality up to 8.8%, so insurers should reassess assumptions.